Status:
SUSPENDED
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Lead Sponsor:
University of Pittsburgh
Conditions:
Chronic Pancreatitis
Inflammatory Bowel Diseases
Eligibility:
All Genders
12+ years
Brief Summary
This is a prospective, descriptive, observational research study designed to observe and document the clinical practice by domain experts, and how the knowledge of new findings that are published in t...
Detailed Description
The Genomic Resource to Enhance Available Therapies (GREAT1.0) Study is a research program for personalized medicine. It is a highly annotated genetic and biosample resource for multiple nested observ...
Eligibility Criteria
Inclusion
- Case Subjects
- Clinical diagnosis of a chronic disease or disorder (ex. pancreatitis, hepatitis or fatty liver, inflammatory bowel disease, irritable bowel syndrome, diarrhea, constipation, chronic pain syndromes, diabetes, hypertension, cardiovascular disease, chronic kidney disease, chronic neurologic disorders, rheumatological disorders, endocrine disorders, chronic pulmonary diseases, sinorespiratory disorders, chronic skin diseases, cancers and related disorders)
- Ability to read and write in English;
- Ability to provide informed consent
- Control Subjects
- • UPMC patients age 12 years without a chronic disorder.
Exclusion
- Chronic infectious disease as the primary medical problem
- Less than 12 years of age
- Inability of the subject to understand the protocol
- Inability to the subject provide informed consent
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
120000 Patients enrolled
Trial Details
Trial ID
NCT04306939
Start Date
November 1 2014
End Date
December 1 2026
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213